Table 2. Matched group analysis.
Characteristic | Antenatal MG ( n = 10) | Control ( n = 10) | p -Value |
---|---|---|---|
Gestational age (wk) (mean ± SD) | 27.6 ± 2.5 | 27.6 ± 2.5 | 1.00 |
Birth weight (g) (mean ± SD) | 1,026 ± 360 | 1,030 ± 329 | 0.98 |
Sex, male n (%) | 5 (50) | 5 (50) | 0.67 |
CRIB II score (mean ± SD) | 8.1 ± 3.6 | 8.2 ± 3.2 | 0.94 |
HsPDA n (%) | 3 (30) | 4 (40) | 0.5 |
PDA Treatment n (%) | 1 (10) | 5 (50) | 0.07 |
Antenatal steroid use | 3 (30) | 5 (50) | 0.32 |
BPD n (%) | 2 (20) | 4 (40) | 0.31 |
NEC n (%) | 1 (10) | 1 (10) | 0.76 |
IVH n (%) | 2 (20) | 2 (20) | 0.71 |
Abbreviations: BPD, Bronchopulmonary dysplasia; CRIB, Clinical risk index for babies; HsPDA, Hemodynamically significant patent ductus arteriosus; IVH, Intraventricular hemorrhage; NEC, Necrotizing enterocolitis; SD, standard deviation; MG, Magniesum sulfate.